Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on presynaptic inhibition by neuropeptide Y in rat hippocampal slices

European Journal of Pharmacology

Volumn 404, Issue 1-2, 2000, Pages 133-136

  Weiser, Thomas ^a   Wieland, Heike A ^a   Doods, Henri N ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

BIIE0246; Hippocampus; Neuropeptide Y; Neuropeptide Y Y2 receptor

Indexed keywords

N 2 [[1 [2 [4 [5,11 DIHYDRO 6(6H) OXODIBENZ[B,E]AZEPIN 11 YL] 1 PIPERAZINYL] 2 OXOETHYL]CYLOPENTYL]ACETYL] N [2 [1,2 DIHYDRO 3,5(4H) DIOXO 1,2 DIPHENYL 3H 1,2,4 TRIAZOL 4 YL]ETHYL]ARGININAMID; N [[4 (AMINOCARBONYLAMINOMETHYL)PHENYL]METHYL] N 2 (DIPHENYLACETYL)ARGININAMIDE TRIFLUOROACETIC ACID; N2 [[1 [2 [4 (5,11 DIHYDRO 6(6H) OXODIBENZ[B,E]AZEPIN 11 YL]PIPERAZINYL] 2 OXOETHYL]CYCLOPENTYL]ACETYL] N [2 (1,2 DIHYDRO 3,5 DIOXO 1,2 DIPHENYL 3H 1,2,4 TRIAZOL 4 YL]ETHYL]ARGINAMIDE; N2 DIPHENYLACETYL N (4 UREIDOMETHYLBENZYL)ARGININAMIDE; NEUROPEPTIDE Y; PEPTIDE YY; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; ELECTROPHYSIOLOGY; HIPPOCAMPUS; MALE; NONHUMAN; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SYNAPTIC TRANSMISSION;

ANIMALS; ARGININE; BENZAZEPINES; BINDING, COMPETITIVE; ELECTROPHYSIOLOGY; HIPPOCAMPUS; MALE; NEURAL INHIBITION; NEUROPEPTIDE Y; RATS; RECEPTORS, NEUROPEPTIDE Y; RECEPTORS, PRESYNAPTIC; SYNAPSES;

EID: 0034666622     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00478-7     Document Type: Article

References (20)

1. Bleakman D., Harrison N.L., Colmers W.F., Miller R.J. Investigations into neuropeptide Y-mediated presynaptic inhibition in cultured hippocampal neurones of the rat. Br. J. Pharmacol. 107:1992;334-340.
2. Colmers W.F., Bleakman D. Effects of neuropeptide Y on the electrical properties of neurons. TINS. 17(9):1994;373-379.
3. Colmers W.F., Lukowiak K.D., Pittman Q.J. Neuropeptide Y reduces orthodromically evoked population spikes in rat hippocampal CAI by a possibly presynaptic mechanism. Brain Res. 346:1985;404-408.
4. Colmers W.F., Lukowiak K.D., Pittman Q.J. Neuropeptide Y action in the rat hippocampal slice: site and mechanism of presynaptic action. J. Neurosci. 8:1988;3827-3837.
5. Colmers W.F., Klapstein G.J., Forunier A., St-Pierre S., Treherne K.A. Presynaptic inhibition by neuropeptide Y in rat hippocampal slice in vitro is mediated by a Y2 receptor. Brain Res. 660:1991;138-143.
6. Doods H., Krause J. Different neuropeptide Y receptor subtypes in rat and rabbit vas deferens. Eur. J. Pharmacol. 204:1991;101-103.
7. Doods H., Gaida W., Wieland H.A., Dollinger H., Schnorrenberg G., Esser F., Engel W., Eberlein W., Rudolf K. BIIE0246: a selective and high affinity neuropeptide Y Y2 receptor antagonist. Eur. J. Pharmacol. 384:1999;R3-R5.
8. 125I]PYY3-36 binding sites in the rat brain evaluated with two newly developed Y1 and Y2 receptor radioligands. Synapse. 22(2):1996;139-158.
9. Erickson J.C., Clegg K.E., Palmiter R.D. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature. 381(6581):1996;415-421.
10. Gerard C., Walker M.W., Criscione L., Gustafson E.L., Batzl-Hartmann C., Smith K.E., Vaysse P., Durkin M.M., Laz T.M., Linemeyer D.L., Schaffhauser A.O., Whitebread S., Hofbauer K.G., Taber R.I., Branchek T.A., Weinshank R.L. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature. 382:1996;168-171.
11. Greber S., Schwarzer C., Sperk G. Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro. Br. J. Pharmacol. 113:1994;737-740.
12. Haas H.L., Hermann A., Greene R.W., Chan-Palay V. Action and location of neuropeptide tyrosine (Y) in hippocampal neurons of the rat slice preparation. J. Comp. Neurol. 257:1987;208-215.
13. Jacques D., Dumont Y., Fournier A., Quirion R. Characterization of neuropeptide Y receptor subtypes in the normal human brain, including the hypothalamus. Neuroscience. 79(1):1997;129-148.
14. Michel M.C., Beck-Sickinger A., Cox H., Doods H., Herzog H., Larhammar D., Quirion R., Schwartz T., Westfall T. XVI International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharm. Rev. 50(1):1998;143-150.
15. Schwarzer C., Kofler N., Sperk G. Up-regulation of neuropeptide Y-Y2 receptors in an animal model of temporal lobe epilepsy. Mol. Pharmacol. 53(1):1998;6-13.
16. Smialowska M., Bijak M., Sopala M., Tokarski K. Inhibitory effect of NPY on the picrotoxin-induced activity in the hippocampus: a behavioural and electrophysiological study. Neuropeptides. 30(1):1996;7-12.
17. Vezzani A., Sperk G., Colmers F.C. Neuropeptide Y: emerging evidence for a functional role in seizure modulation. TINS. 22(1):1999;25-30.
18. Wahlestedt C., Yanaihara N., Hakanson R. Evidence for different pre- and postsynaptic junctional receptors for neuropeptide Y and related properties. Regul. Pept. 13:1985;317-328.
19. Wieland H.A., Willim K., Doods H.N. Receptor binding profiles of NPY analogues and fragments in different tissues and cell lines. Peptides. 16(8):1995;1389-1394.
20. Wieland H.A., Engel W., Eberlein W., Rudolf K., Doods H.N. Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO3304 and its effect on feeding in rodents. Br. J. Pharmacol. 125:1998;549-555.